Completely updated and revised, the 32nd edition of this best-selling reference delivers the latest evidence-based recommendations for the treatment of infectious diseases in children. Each disease is accompanied by expert commentary, helping clinicians choose the best antimicrobial options based on current research and clinical experience. It includes detailed descriptions of all antimicrobial agents available today, with complete dosing regimens. New in the 32nd Edition This edition is fully reviewed for updates, and references are updated throughout the book. Highlights of updated or new guidelines include Chapter 5, "Preferred Therapy for Specific Fungal Pathogens": update to candidiasis therapy for systemic infections Chapter 6, "Choosing Among Antifungal Agents: Polyenes, Azoles, and Echinocandins": dosage updates for posaconazole and isavuconazole Chapter 15, "Antimicrobial Prophylaxis/Prevention of Symptomatic Infection": updates to Table A, "Postexposure Antimicrobial Prophylaxis to Prevent Infection": tuberculosis, neonatal herpes simplex virus Table C, "Prophylaxis of Symptomatic Disease in Children Who Have Asymptomatic Infection/Latent Infection": new information for recurrent mucocutaneous herpes simplex virus Table D, "Surgical Procedure Prophylaxis": intraoperative Re-Dosing interval (h) for prolonged surgery updated throughout; piperacillin/tazobactam therapy added for complicated appendicitis or other ruptured colorectal viscus Chapter 18, Table A, "Systemic Antimicrobials With Dosage Forms and Usual Dosages": now includes Ceftobiprole medocaril sodium, Zevtera Geptotidacin, Blujepa Minocycline ER, Emrosi Paromomycin, Humatin